<DOC>
	<DOCNO>NCT00906035</DOCNO>
	<brief_summary>This research study evaluate effect aspirin dipyridamole alone combination blood flow vessel legs . We examine medication able inhibit clot platelet vessels patient PAD , thereby affect blood flow leg . Platelets cell blood ability adhere form clot .</brief_summary>
	<brief_title>The Vascular Biology Dipyridamole Peripheral Arterial Disease ( PAD )</brief_title>
	<detailed_description>Dipyridamole reformulate guarantee systemic bioavailability steady state level compatible inhibition platelet aggregation ex vivo ( 1 ) . This newly formulate dipyridamole show roughly equal efficacy low dose aspirin secondary prevention stroke drug combination seem roughly additive ( 2 ) . The present study design explore two potential mechanism link dipyridamole action vessel wall ; modulation vascular eicosanoid generation prevention oxidant stress ( 3 ) . We shall address hypothesis dipyridamole affect system patient PAD . These individual disorder platelet-vascular interaction , reflect increased generation thromboxane , index platelet activation prostacyclin , probably homeostatic response traumatic chemical stimulation endothelium ( 4,5 ) . Furthermore , shall assess functional consequence dipyridamole action , alone combination aspirin compare aspirin alone local measurement flow oxygenation , include exercise tolerance , Doppler Ultrasound Near Infrared Spectroscopy ( NIRS ) . Lipid peroxidation quantify base mass spectrometric analysis major urinary isoprostane , 8,12-iso-iPF2a-VI ( 6,7 ) .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<criteria>Age 18 79 Women child bear potential use medically acceptable method birth control ( oral/transdermal/vaginal hormonal contraception , depoprovera injection , IUD , condom spermicide , progestin implant , tubal ligation , oophorectomy , TAH ) abstinence . Capacity give write consent Diagnosis PAD : previous angiogram ( &gt; 0.5 stenosis peripheral artery ) anklebrachial index ( ABI ) systolic pressure &lt; 0.80 previous peripheral revascularization Smokers smoke &lt; 10 cigarette / day Female subject pregnant nursing child . Prior bleed event relate drug therapy History gastrointestinal ulceration History know dipyridamole and/or aspirin allergy intolerance History coagulation , bleed blood disorder . Recent history myocardial infarction stroke previous 6 month Resting blood pressure &lt; 110mmHg systolic &lt; 60mmHg diastolic &gt; 165mmHg systolic &gt; 95mmHg diastolic Patients active infection document abnormal laboratory test screen Concomitant serious illness , cancer , per principal investigator 's discretion Current use steroid chronic disease process Presence ischemic leg ulcer History contact allergy metal lead NIRS History drug alcohol abuse within last 6 month . Subject receive experimental drug and/or use experimental device within 30 day screen . Subject donate â‰¥ one pint blood within 8 week prior screen . Use aspirin 2 week prior study Use NSAID COXinhibitor one week prior start study Use antioxidant vitamin 2 week prior start study Use plavix , pletal trental one week prior start study Use acetaminophen one week prior study visit Use alcohol , caffeine high fat food 24 hour prior study visit Has smoke cigarettes 24 hour prior study visit Platelet aggregation blood test le 60 percent Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>PAD</keyword>
	<keyword>Claudication</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
</DOC>